Gefitinib-based PROTAC 3
CAS: 2230821-27-7
Ref. TM-T5437
| 1mg | 49.00 € | ||
| 2mg | 69.00 € | ||
| 5mg | 94.00 € | ||
| 10mg | 171.00 € | ||
| 25mg | 278.00 € | ||
| 50mg | 424.00 € | ||
| 100mg | 611.00 € |
Estimated delivery in United States, on Thursday 16 May 2024
Product Information
Name:
Gefitinib-based PROTAC 3
Synonyms:
- Gefitinibbased PROTAC 3
CAS:
Description:
Gefitinib-based PROTAC 3, conjugating an EGFR binding element to a VHL ligand via a linker, induces EGFR degradation with DC50s of 11.7 nM and 22.3 nM in HCC827(exon 19 del) and H3255 (L858R mutantion) cells, respectively[1].
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
934.51
Formula:
C47H57ClFN7O8S
Purity:
98.25%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T5437 Gefitinib-based PROTAC 3
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
